Hand-assisted laparoscopic donor nephrectomy of the right or left kidney

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN90285720

Enrollment

Registered

2007-08-23

Start date

2002-04-15

Completion date

Unknown

Last updated

2021-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand-Assisted Laparoscopic Donor Nephrectomy (HALDN) Surgery Kidney transplantation

Interventions

Specific preoperative donor evaluation included blood and urine examination, angiography, pyelography and renal scintigraphy. In case of bilateral multiple arteries they were only included in the stud

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Donors with age above 18 years 2. An identical kidney with regard to renal vascular anatomy 3. Renal function and urinary tract 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Unilateral multiple renal arteries

Design outcomes

Primary

Measure	Time frame
Operation time, measured during operation.	—

Secondary

Measure	Time frame
1. Donor morbidity, measurements were prospectively collected 2. Warm ischaemia time, measured during operation 3. Delayed graft function, measurements were prospectively collected 4. Urological complications, measurements were prospectively collected 5. Graft survival, measurements were prospectively collected until one year after transplantation when most patients went to peripheral centers 6. Quality of life, measured using the following questionnaires: 6.1. 36-item Short Form Health Survey (SF-36): donors received these forms preoperatively and at 1, 2, 4, weeks, 3, 6 and 12 months 6.2. Gastro-Intestinal Quality of Life index (GIQLI): donors received these forms preoperatively and at 1, 2, 4, weeks, 3, 6 and 12 months 6.3. Multidimensional Fatigue Inventory-20 (MFI-20) was administered preoperatively and at 1, 3, 6 and 12 months 6.4. Visual analogue scale (VAS) was measured preoperatively and at day 1, 2, 3, 7 and 28	—

Measure

Time frame

1. Donor morbidity, measurements were prospectively collected 2. Warm ischaemia time, measured during operation 3. Delayed graft function, measurements were prospectively collected 4. Urological complications, measurements were prospectively collected 5. Graft survival, measurements were prospectively collected until one year after transplantation when most patients went to peripheral centers 6. Quality of life, measured using the following questionnaires: 6.1. 36-item Short Form Health Survey (SF-36): donors received these forms preoperatively and at 1, 2, 4, weeks, 3, 6 and 12 months 6.2. Gastro-Intestinal Quality of Life index (GIQLI): donors received these forms preoperatively and at 1, 2, 4, weeks, 3, 6 and 12 months 6.3. Multidimensional Fatigue Inventory-20 (MFI-20) was administered preoperatively and at 1, 3, 6 and 12 months 6.4. Visual analogue scale (VAS) was measured preoperatively and at day 1, 2, 3, 7 and 28

—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026